Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Saved in:
| Title: | Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. |
|---|---|
| Authors: | Hess CN; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado., Szarek M; CPC Clinical Research, Aurora, Colorado.; The State University of New York Downstate Health Sciences University, Brooklyn., Anand SS; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada., Bauersachs RM; Department of Vascular Medicine, Klinikum Darmstadt, Darmstadt, and Center for Thrombosis and Hemostasis, University of Mainz, Mainz, Germany., Patel MR; Duke Clinical Research Institute, Division of Cardiology, Duke University Medical Center, Durham, North Carolina., Debus ES; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany., Nehler MR; CPC Clinical Research, Aurora, Colorado.; University of Colorado School of Medicine, Department of Surgery, Aurora., Capell WH; CPC Clinical Research, Aurora, Colorado.; Division of Endocrinology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora., Beckman JA; Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee., Piazza G; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Henkin S; Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Bura-Rivière A; Toulouse University Hospital, Toulouse, France., Lawall H; Praxis für Herzkreislaufkrankheiten und Akademie für Gefäßkrankheiten, Ettlingen, Germany., Roztocil K; Department of Transplantational Surgery, Institute of Clinical and Experimental Medicine, Prague, Czech Republic., Hsia J; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado., Muehlhofer E; Bayer, Research & Development, Wuppertal, Germany., Berkowitz SD; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado.; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora., Haskell LP; Janssen Research and Development, Raritan, New Jersey., Bonaca MP; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado. |
| Source: | JAMA network open [JAMA Netw Open] 2022 Jun 01; Vol. 5 (6), pp. e2215580. Date of Electronic Publication: 2022 Jun 01. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2022.15580 |
